trending Market Intelligence /marketintelligence/en/news-insights/trending/K4ODf4O8EXjRzcWn8tnlVg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

NovoCure director to retire

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


NovoCure director to retire

Robert Mylod intends to retire as a class II director of NovoCure Ltd., at the company's 2017 annual general meeting of shareholders.

Mylod's decision was not a result of any dispute with the company or its management. He has served on the company's board for five years.